HKEX:2696 - Shanghai Henlius Biotech Inc

Shanghai Henlius Biotech Inc
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance (Live Price)

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts
• Charts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2017	2018	2019	2020	2021	2022	2023	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	1.68B 186.3%	3.21B 91.1%	5.39B 67.8%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	522.75M 187.0%	844.62M 61.6%	1.48B 74.8%
Gross Profit	[friend]	[friend]	[friend]	[friend]	1.16B 186.0%	2.37B 104.4%	3.92B 65.3%
Total Expenses	[friend]	[friend]	[friend]	[friend]	2.31B 56.1%	3.57B 55.0%	4.67B 30.8%
Operating Expense	[friend]	[friend]	[friend]	[friend]	1.78B 37.7%	2.73B 53.1%	3.2B 17.2%
Operating Income	[friend]	[friend]	[friend]	[friend]	-623.18M -	-358.69M -	721.8M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	-956.74M -	-693.89M -	569.58M -
Net Income	[friend]	[friend]	[friend]	[friend]	-984.05M -	-695.26M -	546.02M -
Basic EPS	[friend]	[friend]	[friend]	[friend]	-1.83 -	-1.28 -	1.01 -
Diluted EPS	[friend]	[friend]	[friend]	[friend]	-1.83 -	-1.28 -	1 -